Evidence 1
Activity
Activity
9% Hemolysis
Toxicity
100 µg/mL
Hemolytic
Cytotoxic
9% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Ab initio Designed Antimicrobial Peptides Against Gram-Negative Bacteria | Front Microbiol | 2021